MedTrace Logo

Effects of Vitamin D on Lipids

NCT00723385 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 130

Last updated 2015-04-08

No results posted yet for this study

Summary

The purpose of this study is to examine whether oral vitamin D supplementation in people with inadequate vitamin D concentrations will lower LDL-cholesterol and total cholesterol concentrations.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D (1000 or 2000 IU/day)

Dose titration beginning with 1000 IU/day and either remaining at 1000 IU/day for weeks 7-12 if normalized D levels at 6 weeks or increasing to 2000 IU/day for weeks 7-12 if levels not normalized at week 6

OTHER

Placebo

Administration of placebo for 12 weeks with repeated D measurements

Sponsors & Collaborators

Principal Investigators

  • Janice B. Schwartz, MD,FACC,FAHA · Jewish Home, University of California, San Francisco

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-07-31
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00723385 on ClinicalTrials.gov